Drug Trial Radar · NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
740
Planned (sponsor's estimate)
Start
May 22, 2025
Primary completion
Dec 2035
Study completion Dec 2040
Sponsor
- Lead sponsor
- Eikon TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Merck Sharp & Dohme LLC
- First posted
- Nov 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab.
Conditions
- Advanced Melanoma
Interventions
EIK1001Drug
EIK1001 is a Toll-like receptor 7/8 (TLR 7/8) dual agonist.
Pembrolizumab (KEYTRUDA® )Drug
Pembrolizumab is a PD-1 inhibitor.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free Survival (PFS)Time frame: up to 5 years
- Overall survival (OS)Time frame: up to 5 years
- Objective Response (OR) (Dose Optimization Only)Time frame: up to 5 years
- Adverse Events (AEs) (Dose Optimization Only)Time frame: up to 2.5 years
Locations
127 sites in 24 countries. Site status is shown where the registry gives one.
Ironwood Cancer & Research Centers
Chandler, Arizona · Recruiting
Genesis Cancer and Blood Institute
Hot Springs, Arkansas · Recruiting
Helios Clinical Research
Los Angeles, California · Recruiting
Providence Medical Foundation
Santa Rosa, California · Recruiting
UCHealth Memorial Hospital Central
Colorado Springs, Colorado · Recruiting
Christiana Care
Newark, Delaware · Recruiting
Bioresearch Partner
Hialeah, Florida · Recruiting
Florida Clinical Trials Group - Tamarac
Tamarac, Florida · Recruiting
The Center for Cancer and Blood Disorders
Bethesda, Maryland · Recruiting
MidAmerica Cancer Care
Kansas City, Missouri · Recruiting
Washington University School of Medicine in St. Louis
St Louis, Missouri · Recruiting
Gabrail Cancer Center Research LLC
Canton, Ohio · Recruiting
University of Pittsburgh Medical Center(UPMC)-Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
Patientcare Clinical Research
Sugar Land, Texas · Recruiting
Cancer Care Wollongong
Wollongong, New South Wales, Australia · Recruiting
Icon Cancer Centre Chermside
Chermside, Queensland, Australia · Recruiting
Southern Adelaide Local Health Network Incorporated Flinders Medical Centre
Bedford Park, South Australia, Australia · Recruiting
Eastern Health
Box Hill, Victoria, Australia · Recruiting
Peninsula and South Eastern Haematology and Oncology Group
Frankston, Victoria, Australia · Recruiting
Universitätsklinikum Graz
Graz, Styria, Austria · Recruiting
Vitaz Primary Location
Sint-Niklaas, Belgium · Recruiting
Universitair Ziekenhuis Antwerpen
Edegem, Antwerpen, Belgium · Recruiting
Cliniques Universitaires Saint-Luc
Brussels, Brussels Capital, Belgium · Recruiting
Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne
Yvoir, Namur, Belgium · Recruiting
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Vlaams Brabant, Belgium · Recruiting
Algemeen Ziekenhuis Groeninge - Campus Kennedylaan
Kortrijk, West-Vlaanderen, Belgium · Recruiting
Sunnybrook Research Ins<tute
Toronto, Ontario, Canada · Recruiting
Masaryk Memorial Cancer Institute
Brno, Brno, Czechia · Recruiting
University Hospital Hradec Kralove
Sokolov, Hradce Kralove, Czechia · Recruiting
Aarhus Universitetshospital
Aarhus, Central Jutland, Denmark · Suspended
Aalborg University Hospital
Aalborg, Nord Jutland, Denmark · Suspended
Oulu University Hospital
Oulu, Oulu, Finland · Recruiting
Tampere University Hospital
Tampere, Pirkanmaa, Finland · Recruiting
Helsinki University Hospital
Helsinki, Uusimaa, Finland · Recruiting
Hospital Saint Andre
Bordeaux, France · Recruiting
Centre Hospitalier Lyon-Sud
Pierre-Bénite, Auvergne-Rhône-Alpes, France · Recruiting
A Paré
Boulogne, Boulogne, France · Recruiting
Centre Hospitalier Universitaire Grenoble Alpes
La Tronche, Isère, France · Recruiting
CHU Lille
Lille, Lille Cedex, France · Recruiting
Hôpital La Timone
Marseille, Marseille, France · Recruiting
Showing 40 of 127 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.